Von Willebrand Factor (Factor VIII RA)
Regulatory status: IVD, FDA Class I
60-0109-7 7mL RTU
61-0109 1mL concentrate
This antibody must be used in conjunction with other more sensitive markers of endothelial cells (e.g. CD34 and CD31) for identifying anglosarcomas. There is overlap between the expression of Von Willebrand Factor (VWF) in vascular and lymphatic endothelium. This antibody may be helpful when used in a panel of antibodies.